MESO

Mesoblast Limited - ADR

18.70

USD

MESO Earnings Reports

Positive Surprise Ratio

MESO beat 8 of 10 last estimates.

80%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q2 26 (Revenue/ EPS)

$52.52M

-$0.15

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q2 25 (Revenue/ EPS)

Mesoblast Limited - ADR earnings per share and revenue

On --, MESO reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 52.52 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Mesoblast Limited - ADR's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Mesoblast Limited - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Mesoblast Limited - ADR's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Mesoblast Limited - ADR expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Mesoblast Limited - ADR's next earnings report?

Based on 4 analysts, Mesoblast Limited - ADR is expected to report EPS of -$0.15 and revenue of $52.52M for Q2 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.